Gupta, D. L., J. Meher, A. K. Giri, A. K. Shukla, E. Mohapatra, M. M. Ruikar, and D. Rao. “RBD Mutations at the Residues K417, E484, N501 Reduced Immunoreactivity With Antisera from Vaccinated and COVID-19 Recovered Patients”. Drug Target Insights, vol. 18, no. 1, May 2024, pp. 20-26, doi:10.33393/dti.2024.3059.